Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$601M |
| 2 |
Gilead Sciences
GILD
|
+$574M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
Altria Group
MO
|
+$370M |
| 5 |
WIX.com
WIX
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$581M |
| 2 |
eBay
EBAY
|
+$465M |
| 3 |
Lam Research
LRCX
|
+$300M |
| 4 |
Becton Dickinson
BDX
|
+$267M |
| 5 |
UnitedHealth
UNH
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Financials | 11.82% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XRN
3001
Chiron Real Estate Inc
XRN
$477M
| $1.61M | ﹤0.01% |
46,396
+7,123
| +18% | +$248K |
|
3002
Deutsche Bank
DB
$71.5B
| $1.61M | ﹤0.01% |
54,907
-16,837
| -23% | -$445K |
|
3003
Dimensional US Core Equity 2 ETF
DFAC
$49.4B
| $1.61M | ﹤0.01% |
44,846
+9,894
| +28% | +$330K |
|
3004
Select Water Solutions
WTTR
$2.61B
| $1.6M | ﹤0.01% |
185,514
+38,416
| +26% | +$331K |
|
3005
Madison Square Garden
MSGE
$3.62B
| $1.6M | ﹤0.01% |
40,030
-71,003
| -64% | -$2.51M |
|
3006
Orion Group Holdings
ORN
$418M
| $1.6M | ﹤0.01% |
176,373
+30,185
| +21% | +$226K |
|
3007
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
| $1.6M | ﹤0.01% |
19,330
+459
| +2% | +$35.1K |
|
|
SLNO
3008
DELISTED
Soleno Therapeutics
SLNO
| $1.59M | ﹤0.01% |
19,035
-11,678
| -38% | -$874K |
|
3009
Pacer Trendpilot 100 ETF
PTNQ
$1.26B
| $1.59M | ﹤0.01% |
22,338
-1,677
| -7% | -$114K |
|
3010
NB Bancorp
NBBK
$989M
| $1.59M | ﹤0.01% |
88,900
+9,600
| +12% | +$162K |
|
|
AVNS
3011
DELISTED
Avanos Medical
AVNS
| $1.58M | ﹤0.01% |
129,475
-16,731
| -11% | -$210K |
|
3012
Great Southern Bancorp
GSBC
$878M
| $1.58M | ﹤0.01% |
26,935
+458
| +2% | +$25.6K |
|
|
SHOE
3013
Shoe Station Group
SHOE
$428M
| $1.58M | ﹤0.01% |
84,593
+42,322
| +100% | +$805K |
|
|
LENZ
3014
LENZ Therapeutics
LENZ
$168M
| $1.58M | ﹤0.01% |
53,943
-12,087
| -18% | -$329K |
|
3015
iShares China Large-Cap ETF
FXI
$4.31B
| $1.58M | ﹤0.01% |
42,993
-65
| -0.2% | -$2.28K |
|
3016
Genesco
GCO
$422M
| $1.58M | ﹤0.01% |
80,253
-7,617
| -9% | -$159K |
|
3017
Invesco DB Energy Fund
DBE
$85.3M
| $1.57M | ﹤0.01% |
84,035
+16,234
| +24% | +$294K |
|
3018
TriplePoint Venture Growth BDC
TPVG
$211M
| $1.56M | ﹤0.01% |
223,483
-58,126
| -21% | -$381K |
|
3019
OneWater Marine
ONEW
$201M
| $1.56M | ﹤0.01% |
116,662
+31,410
| +37% | +$445K |
|
|
AGNT
3020
AGNT Inc
AGNT
$734M
| $1.56M | ﹤0.01% |
171,401
-21,751
| -11% | -$190K |
|
3021
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
| $1.55M | ﹤0.01% |
59,639
+7,802
| +15% | +$209K |
|
3022
iShares US Pharmaceuticals ETF
IHE
$1.64B
| $1.55M | ﹤0.01% |
23,658
+19,661
| +492% | +$1.28M |
|
|
SAGE
3023
DELISTED
Sage Therapeutics
SAGE
| $1.55M | ﹤0.01% |
169,860
+104,202
| +159% | +$766K |
|
3024
AllianceBernstein
AB
$3.47B
| $1.55M | ﹤0.01% |
37,889
-124
| -0.3% | -$4.86K |
|
|
FFWM
3025
DELISTED
First Foundation Inc
FFWM
| $1.54M | ﹤0.01% |
302,829
-3,962
| -1% | -$20.3K |
|
Similar funds
Ameriprise's Q2 2025 Portfolio in Review
As of Q2 2025, Ameriprise held 4,177 positions worth $406B, up 9.5% from $370B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q2 2025 filing shows 166 new, 1,840 increased, 1,831 reduced and 222 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M. The largest sale was AbbVie, an estimated $581M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M.
- Ameriprise added most to Alphabet (Google) Class A in Q2 2025, an estimated $601M increase.
- Ameriprise's biggest Q2 2025 reduction was AbbVie, cutting an estimated $581M.
- Ameriprise fully exited Discover Financial Services in Q2 2025, selling an estimated $111M.
- Ameriprise's ten largest holdings make up 21% of its $406B portfolio in Q2 2025.
- Ameriprise opened 166 new positions and closed 222 in Q2 2025.
- Ameriprise's portfolio value rose 9.5% quarter-over-quarter to $406B.
Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.